Log in

NASDAQ:BOLDAudentes Therapeutics SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$59.97
0.00 (0.00 %)
(As of 01/15/2020)
Add
Compare
Today's Range
$59.97
Now: $59.97
$59.97
50-Day Range
$59.97
MA: $59.97
$59.97
52-Week Range
$22.00
Now: $59.97
$60.00
VolumeN/A
Average Volume1.50 million shs
Market Capitalization$2.77 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.18

SEC Filings

Audentes Therapeutics (NASDAQ:BOLD) SEC Filings

DateFilerForm TypeView
02/14/2020
3:20 PM
Audentes Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
01/27/2020
8:38 AM
Audentes Therapeutics (Filer)
Form 15-12B
01/20/2020
11:15 PM
Audentes Therapeutics (Filer)
Form EFFECT
01/20/2020
11:15 PM
Audentes Therapeutics (Filer)
Form EFFECT
01/15/2020
12:38 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:37 PM
Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:36 PM
Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:35 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:34 PM
Audentes Therapeutics (Issuer)
Mosbrooker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:33 PM
Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:32 PM
Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:31 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:30 PM
Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:29 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:27 PM
Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
12:26 PM
Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
11:56 AM
Audentes Therapeutics (Filer)
Form POSASR
01/15/2020
11:51 AM
Audentes Therapeutics (Filer)
Form POS AM
01/15/2020
11:49 AM
Audentes Therapeutics (Filer)
Form POS AM
01/15/2020
11:38 AM
Audentes Therapeutics (Filer)
Form S-8 POS
01/15/2020
11:37 AM
Audentes Therapeutics (Filer)
Form S-8 POS
01/15/2020
11:36 AM
Audentes Therapeutics (Filer)
Form S-8 POS
01/15/2020
11:34 AM
Audentes Therapeutics (Filer)
Form S-8 POS
01/15/2020
9:59 AM
Audentes Therapeutics (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
01/15/2020
9:03 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2020
5:12 AM
Audentes Therapeutics (Subject)
Form SC 14D9/A
01/15/2020
5:10 AM
Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
Form SC TO-T/A
01/10/2020
5:19 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
5:18 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2020
4:08 PM
Audentes Therapeutics (Subject)
Form SC 14D9/A
01/07/2020
4:03 PM
Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
Form SC TO-T/A
01/07/2020
9:17 AM
Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/27/2019
7:23 PM
Audentes Therapeutics (Subject)
Form SC 14D9/A
12/27/2019
6:25 PM
Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
Form SC TO-T/A
12/27/2019
3:10 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
5:05 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
5:04 PM
Audentes Therapeutics (Issuer)
Mosbrooker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
5:04 PM
Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
5:03 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
5:02 PM
Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
5:51 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
5:14 AM
Audentes Therapeutics (Subject)
Form SC 14D9
12/16/2019
5:10 AM
Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
Form SC TO-T
12/09/2019
4:17 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
4:16 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
4:15 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
3:01 PM
Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
Form SC TO-C
12/04/2019
3:04 PM
Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
Form SC TO-C
12/02/2019
8:53 PM
Audentes Therapeutics (Subject)
Form SC14D9C
12/02/2019
8:38 PM
Astellas Pharma Inc. (Filed by)
Audentes Therapeutics (Subject)
Form SC TO-C
11/12/2019
4:32 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
11:11 AM
Audentes Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/07/2019
4:16 PM
Audentes Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
3:06 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
8:54 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
5:11 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
3:17 PM
Audentes Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G
09/09/2019
3:06 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:05 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:04 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
3:02 PM
Audentes Therapeutics (Filer)
Form 8-K/A
08/14/2019
6:03 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
7:43 PM
Audentes Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:06 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2019
3:26 PM
Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
3:24 PM
Audentes Therapeutics (Issuer)
Conner Edward R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/26/2019
3:07 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:42 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:41 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:41 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:40 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:30 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
3:02 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
3:42 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
8:30 PM
Audentes Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:03 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
1:15 PM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:30 PM
Audentes Therapeutics (Filer)
Form DEFA14A
04/26/2019
3:30 PM
Audentes Therapeutics (Filer)
Form DEF 14A
04/08/2019
6:11 AM
Audentes Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
4:54 PM
Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
4:53 PM
Audentes Therapeutics (Issuer)
Meltz Mark A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2019
4:03 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
4:16 PM
Audentes Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2019
3:32 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:31 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
4:22 PM
Audentes Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
02/14/2019
12:51 PM
Audentes Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
02/12/2019
8:42 AM
Audentes Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/08/2019
4:50 PM
Audentes Therapeutics (Issuer)
Patterson Matthew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:29 PM
Audentes Therapeutics (Issuer)
Soloway Thomas P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:28 PM
Audentes Therapeutics (Issuer)
Smith Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:27 PM
Audentes Therapeutics (Issuer)
Schuetz Thomas J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:25 PM
Audentes Therapeutics (Issuer)
PRASAD SUYASH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:23 PM
Audentes Therapeutics (Issuer)
Morrison Scott W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:22 PM
Audentes Therapeutics (Issuer)
LANGE LOUIS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:21 PM
Audentes Therapeutics (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:20 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:20 PM
Audentes Therapeutics (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
6:28 PM
Audentes Therapeutics (Issuer)
Holles Natalie C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.